Search results
Author(s):
Syed Yaseen Naqvi
,
Ibrahim G Salama
,
Ayhan Yoruk
,
et al
Added:
3 years ago
Heart failure is a progressive and fatal disease that affects more than 23 million people worldwide, and will affect more than 8 million people in the USA by 2030.1,2 Despite major advancements in medical and device treatments for heart failure in recent decades, the incidence of heart failure continues to rise. This epidemic has a major impact on patient quality of life, while imposing heavy…
View more
Author(s):
Karine Grigoryan
,
Camelia Demetrescu
,
Ioannis Kasouridis
,
et al
Added:
1 year ago
Author(s):
Aniket S Rali
,
Siva Taduru
,
Lena E Tran
,
et al
Added:
1 year ago
Author(s):
Federica Jiritano
,
Valeria Lo Coco
,
Matteo Matteucci
,
et al
Added:
3 years ago
Cardiogenic shock (CS) is a circulatory failure as a consequence of left, right or biventricular dysfunction.1 It leads to critical end-organ hypoperfusion due to primary cardiac dysfunction.1 Therefore, CS is not only a cardiac disease but also a multiorgan dysfunction syndrome involving the entire circulatory system, often complicated by a systemic inflammatory response syndrome.2 The goals of…
View more
Author(s):
Augusto D Pichard
Added:
5 years ago
Prof Augusto Pichard (MedStar Washington Hospital Center, Washington DC, US) discusses the Portico self-expanding aortic valve - latest iterations and status of trial.
Filmed on site at CRT 2019 by Radcliffe Cardiology.
Questions:
1. Could you give us a brief narrative of data published on the Portico valve to date?
2. Which patients do you use the Portico Valve in?
3. For implantors, not…
View more
Author(s):
Maurizio Bertaina
,
Alessandro Galluzzo
,
Nuccia Morici
,
et al
Added:
1 year ago
Heart Block Post-TAVR
Author(s):
Anthony J Mazzella
,
Sameer Arora
,
Michael J Hendrickson
,
et al
Added:
2 years ago
Article
Author(s):
Vineet Agrawal
,
Kelly A Costopoulos
,
Mohammed Chowdhary
,
et al
Added:
2 years ago
Author(s):
Tania Deis
,
Kasper Rossing
,
Finn Gustafsson
Added:
1 year ago
Author(s):
Ernest Spitzer
,
Rebecca T Hahn
,
Philippe Pibarot
,
et al
Added:
3 years ago
Symptomatic severe aortic stenosis (AS) is the most common indication for valvular interventions.1 AS is a degenerative and progressive disease that characteristically remains asymptomatic for decades but once symptoms occur, survival is severely compromised. Historical data have shown that the time from the onset of symptoms to death is about 2 years in patients who develop heart failure (HF)…
View more